Literature DB >> 21825843

Iodine-123 metaiodobenzylguanidine cardiac imaging as a method to detect early sympathetic neuronal dysfunction in chagasic patients with normal or borderline electrocardiogram and preserved ventricular function.

Maria Carolina P Landesmann1, Lea Mirian Barbosa da Fonseca, Basilio de B Pereira, Emília M do Nascimento, Paulo Henrique Rosado-de-Castro, Sergio Augusto Lopes de Souza, Ronaldo de S L Lima, Roberto C Pedrosa.   

Abstract

PURPOSE: The indeterminate form of Chagas disease represents the most common chronic presentation. The aim of this study was to assess cardiovascular autonomic system function with I-123 metaiodobenzylguanidine (MIBG) scintigraphy in chagasic patients with normal or "borderline" electrocardiographic alterations and preserved left ventricular function evaluated by echocardiography.
MATERIALS AND METHODS: A total of 40 chagasic patients and 19 control subjects were included in this study. Patients had normal echocardiogram and chest radiography; no arrhythmias or myocardial ischemia; and normal exercise performance for age, gender, and body mass index. I-123 MIBG scintigraphy was performed and the heart-to-mediastinum (H/M) uptake was used as the primary predictor in the present analysis. The data analysis was performed by using Nonparametric Regression Trees and the Survival Agreement Plot. We included only patients with preserved right and left ventricular function assessed by echocardiographic methods.
RESULTS: Variables analyzed in the regression tree were age, sex, 20 minutes and 3 hours H/M uptake after injection of I-123 MIBG, washout rate, and single photon emission computed tomography imaging. The 3 hours H/M ratio was the only significant variable (P<0.001) and for 95% of chagasic patients, this value was less than 2.19.
CONCLUSIONS: This study presents evidence that cardiac autonomic sympathetic modulation may be affected in chagasic subjects with preserved ventricular function evaluated by echocardiography, especially in those with "borderline" electrocardiogram.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21825843     DOI: 10.1097/RLU.0b013e31821772a9

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

Review 1.  Developments in the management of Chagas cardiomyopathy.

Authors:  Herbert B Tanowitz; Fabiana S Machado; David C Spray; Joel M Friedman; Oren S Weiss; Jose N Lora; Jyothi Nagajyothi; Diego N Moraes; Nisha Jain Garg; Maria Carmo P Nunes; Antonio Luiz P Ribeiro
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-23

2.  Causing Mechanisms of Embolic Strokes in Chagas Heart Disease: Autonomic Dysfunction, a Working Hypothesis.

Authors:  Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

3.  Relationship between Urinary Norepinephrine, Fibrosis, and Arrhythmias in Chronic Chagas Heart Disease with Preserved or Mildly Reduced Ejection Fraction.

Authors:  Eduardo Marinho Tassi; Emília Matos do Nascimento; Marcelo Abramoff Continentino; Basilio de Bragança Pereira; Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

Review 4.  New Imaging Parameters to Predict Sudden Cardiac Death in Chagas Disease.

Authors:  Renata J Moll-Bernardes; Paulo Henrique Rosado-de-Castro; Gabriel Cordeiro Camargo; Fernanda Souza Nogueira Sardinha Mendes; Adriana S X Brito; Andréa Silvestre Sousa
Journal:  Trop Med Infect Dis       Date:  2020-05-08

5.  Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients.

Authors:  Viviane Santuari Parisotto Marino; Sandra Monetti Dumont; Luciene das Graças Mota; Daniela de Souza Braga; Stephanie Saliba de Freitas; Maria da Consolação Vieira Moreira
Journal:  Arq Bras Cardiol       Date:  2018-08-06       Impact factor: 2.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.